[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"neuron-disease-motor\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:neuron-disease-motor":39},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":5},"100560971",false,"NCT06584084","Technical and Clinical Validation of the WPM-SEMG Prototype","Technical and Clinical Validation Study of a New Wireless Portable and Multi-Channel Surface EMG Device to Analyse Motor Unit Action Potentials","Eligibility criteria for healthy volunteers\n\n* Inclusion Criteria\n\n  * Healthy volunteers\n  * Female or male\n  * 18 years or older\n  * Preserved cognitive capacity\n  * Ability to understand the study\n  * Willingness to complete all the study assessments\n  * No chronic or concomitant use of medications or treatment\n  * Written informed consent\n* Exclusion Criteria\n\n  * Skin lesions in the area below the electrode\n  * Allergy to metal alloys\n  * History of skin disease\n  * Pregnancy\n  * Lactation\n  * Known causes of neuromuscular disease\n  * Inability to follow the procedures of the study\n\nEligibility criteria for patients\n\n* Inclusion Criteria\n\n  * Patients of the Neurocentro della Svizzera Italiana with diagnosis of myopathy or neuropathy that requires a needle-EMG electrophysiological testing as standard clinical management of the disease\n  * Female or male\n  * 18 years or older\n  * Preserved cognitive capacity\n  * Ability to understand the study\n  * Willingness to complete all the study assessments\n  * No chronic or concomitant use of medications or treatment that may influence the measure in the opinion of the investigator (muscle relaxant such as baclofen, statin, benzodiazepine).\n  * Written informed consent\n* Exclusion Criteria\n\n  * Skin lesions in the area below the electrode\n  * Allergy to metal alloys\n  * History of skin disease\n  * Cognitive and\u002For psychiatric disorders\n  * Pregnancy\n  * Lactation\n  * Neuromuscular disease other than myopathy and neuropathy\n  * Inability to follow the procedures of the study",true,"ALL","18 Years",{"count":19,"type":20},70,"ESTIMATED","INTERVENTIONAL",[23],"NA","Validation study designed to demonstrate the technical and clinical performance, and the safety of a new medical device in healthy volunteers and patients with myopathy or neuropathy. The medical device is the WPM-SEMG prototype designed for recording electrophysiological signals of muscles.",[26],"Neuron Disease, Motor","RECRUITING","2024-09-04",{"date":30,"type":31},"2024-09-19","ACTUAL",{"date":33,"type":31},"2018-01-19",{"date":35,"type":20},"2026-04-30",{"name":37,"class":38},"Alain Kaelin","OTHER",""]